Pediatrix Medical Group, Inc. (MD) 10-Year Financial Performance & Capital Metrics

MD • • Industrial / General

HealthcareHealthcare FacilitiesSpecialized Medical ServicesPediatric & Maternal Specialists

AboutPediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.Show more

Revenue $2.01B +0.9%
EBITDA -$36M -183.9%
Net Income -$99M -64.0%
EPS (Diluted) -1.19 -63.0%
Gross Margin 22.57% +6.8%
EBITDA Margin -1.81% -183.1%
Operating Margin -3.41% -1030.1%
Net Margin -4.92% -62.5%
ROE -12.28% -76.9%
ROIC -3.85% -1179.4%
Debt/Equity 0.87 +4.8%
Interest Coverage -1.69 -1069.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 81 (top 19%)

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-1.9%

5Y2.49%

3Y1.74%

TTM-4.21%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM163.89%

EPS CAGR

10Y-

5Y-

3Y-

TTM161.44%

ROCE

10Y Avg6.45%

5Y Avg3.11%

3Y Avg1.57%

Latest-3.87%

Peer Comparison

Pediatric & Maternal Specialists

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
MDPediatrix Medical Group, Inc.	1.95B	22.67	-19.05	0.92%	8.44%	18.21%	9.48%	0.87

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.78B	3.18B	3.46B	3.65B	1.78B	1.73B	1.91B	1.97B	1.99B	2.01B
Revenue Growth %	0.14%	0.15%	0.09%	0.05%	-0.51%	-0.03%	0.1%	0.03%	0.01%	0.01%
Cost of Goods Sold+	1.85B	2.15B	2.46B	2.66B	1.28B	1.28B	1.4B	1.5B	1.57B	1.56B
COGS % of Revenue	0.67%	0.68%	0.71%	0.73%	0.72%	0.74%	0.73%	0.76%	0.79%	0.77%
Gross Profit+	928.01M	1.03B	1B	989.51M	503.09M	449.32M	513.24M	467.03M	421.56M	454.34M
Gross Margin %	0.33%	0.32%	0.29%	0.27%	0.28%	0.26%	0.27%	0.24%	0.21%	0.23%
Gross Profit Growth %	0.15%	0.11%	-0.03%	-0.01%	-0.49%	-0.11%	0.14%	-0.09%	-0.1%	0.08%
Operating Expenses+	370.14M	461.84M	519.98M	543.66M	331.33M	351.19M	310.32M	294.35M	414.24M	523.06M
OpEx % of Revenue	0.13%	0.15%	0.15%	0.15%	0.19%	0.2%	0.16%	0.15%	0.21%	0.26%
Selling, General & Admin	305.92M	372.57M	417.11M	432.38M	244.51M	248.95M	263.36M	231.4M	227.54M	238.44M
SG&A % of Revenue	0.11%	0.12%	0.12%	0.12%	0.14%	0.14%	0.14%	0.12%	0.11%	0.12%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	64.23M	89.26M	102.88M	111.28M	86.82M	102.24M	46.97M	62.95M	186.7M	284.62M
Operating Income+	557.87M	571.69M	480.08M	445.85M	171.76M	98.13M	202.92M	172.69M	7.32M	-68.71M
Operating Margin %	0.2%	0.18%	0.14%	0.12%	0.1%	0.06%	0.11%	0.09%	0%	-0.03%
Operating Income Growth %	0.09%	0.02%	-0.16%	-0.07%	-0.61%	-0.43%	1.07%	-0.15%	-0.96%	-10.39%
EBITDA+	622.1M	660.95M	582.96M	529.68M	197.69M	126.57M	235.06M	208.32M	43.49M	-36.49M
EBITDA Margin %	0.22%	0.21%	0.17%	0.15%	0.11%	0.07%	0.12%	0.11%	0.02%	-0.02%
EBITDA Growth %	0.11%	0.06%	-0.12%	-0.09%	-0.63%	-0.36%	0.86%	-0.11%	-0.79%	-1.84%
D&A (Non-Cash Add-back)	64.23M	89.26M	102.88M	83.83M	25.93M	28.44M	32.15M	35.64M	36.17M	32.23M
EBIT	557.87M	571.69M	460.23M	443.85M	177.71M	117.63M	203.95M	121.06M	-6.28M	-60.6M
Net Interest Income+	-23.11M	-63.09M	-74.56M	-92.94M	-118.93M	-110.48M	-68.72M	-39.7M	-42.08M	-40.74M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	23.11M	63.09M	74.56M	92.94M	118.93M	110.48M	68.72M	39.7M	42.08M	40.74M
Other Income/Expense	-18.14M	-57.89M	-69.65M	120.45M	-112.97M	-90.98M	-67.69M	-91.32M	-55.68M	-32.63M
Pretax Income+	539.73M	513.8M	410.42M	368.84M	58.78M	7.15M	135.23M	81.37M	-48.36M	-101.34M
Pretax Margin %	0.19%	0.16%	0.12%	0.1%	0.03%	0%	0.07%	0.04%	-0.02%	-0.05%
Income Tax+	204.04M	189.2M	90.05M	100.21M	16.58M	16.73M	27.24M	18.81M	12.05M	-2.27M
Effective Tax Rate %	0.62%	0.63%	0.78%	0.73%	-25.48%	-111.43%	0.97%	0.82%	1.25%	0.98%
Net Income+	336.32M	324.91M	320.37M	268.63M	-1.5B	-796.49M	130.96M	66.33M	-60.41M	-99.07M
Net Margin %	0.12%	0.1%	0.09%	0.07%	-0.84%	-0.46%	0.07%	0.03%	-0.03%	-0.05%
Net Income Growth %	0.06%	-0.03%	-0.01%	-0.16%	-6.58%	0.47%	1.16%	-0.49%	-1.91%	-0.64%
Net Income (Continuing)	335.69M	324.6M	305.44M	258.61M	42.21M	-9.58M	107.99M	62.56M	-60.41M	-99.07M
Discontinued Operations	0	0	14.93M	147.12M	-1.54B	-786.91M	22.95M	3.77M	0	0
Minority Interest	318K	0	0	0	0	232K	205K	0	0	0
EPS (Diluted)+	3.58	3.47	3.42	2.93	-17.94	-9.55	1.52	0.79	-0.73	-1.19
EPS Growth %	0.13%	-0.03%	-0.01%	-0.14%	-7.12%	0.47%	1.16%	-0.48%	-1.92%	-0.63%
EPS (Basic)	3.59	3.47	3.42	2.95	-17.78	-9.31	1.52	0.80	-0.72	-1.19
Diluted Shares Outstanding	93.96M	93.72M	93.72M	91.61M	84.25M	85.59M	86.42M	84.12M	82.2M	83.33M
Basic Shares Outstanding	93.74M	92.42M	92.43M	91.1M	84.25M	85.59M	86.42M	82.95M	84.02M	83.33M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	527.77M	587.13M	627.24M	657.41M	731.51M	1.55B	840.56M	427.99M	483.45M	639.61M
Cash & Short-Term Investments	60.42M	66.98M	70.49M	58.67M	182.38M	1.23B	487.11M	103.06M	177.74M	348.51M
Cash Only	51.57M	55.7M	60.2M	36.74M	107.87M	1.12B	387.39M	9.82M	73.26M	229.94M
Short-Term Investments	8.85M	11.29M	10.29M	21.92M	74.51M	104.87M	99.72M	93.24M	104.48M	118.57M
Accounts Receivable	444.74M	495.28M	504M	506.72M	434.27M	241.93M	316.02M	296.79M	279.88M	272.6M
Days Sales Outstanding	58.39	56.79	53.19	50.71	89.06	50.93	60.35	54.93	51.22	49.43
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	12.97M	13.82M	37.16M	88.72M	97.75M	61.81M	18.9M	13.26M	12.31M	5.09M
Total Non-Current Assets+	4.02B	4.75B	5.24B	5.28B	3.41B	1.8B	1.88B	1.92B	1.74B	1.51B
Property, Plant & Equipment	83.63M	103.07M	123.54M	133.04M	129.09M	132.16M	135.62M	140.21M	145.93M	78.44M
Fixed Asset Turnover	33.24x	30.88x	27.99x	27.41x	13.79x	13.12x	14.09x	14.06x	13.67x	25.66x
Goodwill	3.37B	4.08B	4.6B	4.69B	1.48B	1.48B	1.51B	1.53B	1.38B	1.24B
Intangible Assets	424.22M	668.53M	639.93M	588.31M	28.59M	26.64M	21.57M	18.49M	21.24M	11.6M
Long-Term Investments	63.29M	78.97M	80.68M	69.7M	0	0	0	0	0	0
Other Non-Current Assets	-335.88M	-409.85M	-352.01M	-333.98M	1.69B	107.36M	131.03M	123.18M	82.17M	76.6M
Total Assets+	4.55B	5.34B	5.87B	5.93B	4.15B	3.35B	2.72B	2.35B	2.22B	2.15B
Asset Turnover	0.61x	0.60x	0.59x	0.61x	0.43x	0.52x	0.70x	0.84x	0.90x	0.94x
Asset Growth %	0.26%	0.17%	0.1%	0.01%	-0.3%	-0.19%	-0.19%	-0.14%	-0.05%	-0.03%
Total Current Liabilities+	395.81M	407.94M	438.02M	469.34M	541.82M	444.33M	427.37M	426.98M	388.95M	434.11M
Accounts Payable	21.97M	28.47M	34.63M	31.06M	35.41M	59.77M	36.65M	31.86M	34.59M	46.43M
Days Payables Outstanding	4.33	4.83	5.14	4.27	10.12	16.98	9.57	7.73	8.03	10.87
Short-Term Debt	11.88M	22.05M	1.4M	253K	0	0	0	12.5M	12.5M	18.75M
Deferred Revenue (Current)	-1000K	-1000K	-1000K	-1000K	0	0	0	0	0	0
Other Current Liabilities	100.56M	107.9M	192.89M	149.89M	106.89M	0	0	0	0	0
Current Ratio	1.33x	1.44x	1.43x	1.40x	1.35x	3.49x	1.97x	1.00x	1.24x	1.47x
Quick Ratio	1.33x	1.44x	1.43x	1.40x	1.35x	3.49x	1.97x	1.00x	1.24x	1.47x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	1.71B	2.17B	2.36B	2.38B	2.11B	2.16B	1.4B	1.03B	981.8M	953.65M
Long-Term Debt	1.26B	1.68B	1.85B	1.97B	1.73B	1.73B	1B	627.65M	611.59M	593.57M
Capital Lease Obligations	2.42M	1.5M	0	188K	44.64M	49.87M	41.4M	52.94M	54.07M	35.49M
Deferred Tax Liabilities	188.96M	227.8M	147.8M	131.24M	56.47M	61.75M	41.41M	33.64M	34.31M	34.25M
Other Non-Current Liabilities	228.82M	218.25M	418.4M	372.55M	273.74M	310.62M	313.43M	315.04M	281.84M	290.34M
Total Liabilities	2.11B	2.58B	2.8B	2.85B	2.65B	2.6B	1.83B	1.46B	1.37B	1.39B
Total Debt+	1.27B	1.71B	1.85B	1.97B	1.79B	1.8B	1.07B	717.08M	701.65M	662.31M
Net Debt	1.22B	1.65B	1.79B	1.94B	1.69B	680.84M	678.44M	707.26M	628.39M	432.37M
Debt / Equity	0.52x	0.62x	0.60x	0.64x	1.20x	2.41x	1.19x	0.80x	0.83x	0.87x
Debt / EBITDA	2.05x	2.58x	3.18x	3.73x	9.07x	14.26x	4.53x	3.44x	16.13x	-
Net Debt / EBITDA	1.97x	2.50x	3.08x	3.66x	8.52x	5.38x	2.89x	3.39x	14.45x	-
Interest Coverage	24.14x	9.06x	6.44x	4.80x	1.44x	0.89x	2.95x	4.35x	0.17x	-1.69x
Total Equity+	2.44B	2.76B	3.07B	3.09B	1.5B	747.72M	896.69M	891.63M	849.06M	764.94M
Equity Growth %	0.08%	0.13%	0.11%	0.01%	-0.51%	-0.5%	0.2%	-0.01%	-0.05%	-0.1%
Book Value per Share	25.95	29.46	32.72	33.71	17.79	8.74	10.38	10.60	10.33	9.18
Total Shareholders' Equity	2.44B	2.76B	3.07B	3.09B	1.5B	747.49M	896.49M	891.63M	849.06M	764.94M
Common Stock	937K	937K	937K	878K	842K	856K	864K	829K	840K	859K
Retained Earnings	1.51B	1.79B	2.05B	2.09B	510.13M	-286.35M	-155.39M	-89.06M	-149.47M	-248.54M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-119.33M	-143.71M	-169.62M	-207.82M	78K	3.53M	1.32M	-3.73M	-2.21M	-1.07M
Minority Interest	318K	0	0	0	0	232K	205K	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	368.7M	443.78M	511.38M	289.93M	357.71M	204.62M	76.74M	166.94M	137.32M	206.57M
Operating CF Margin %	0.13%	0.14%	0.15%	0.08%	0.2%	0.12%	0.04%	0.08%	0.07%	0.1%
Operating CF Growth %	-0.13%	0.2%	0.15%	-0.43%	0.23%	-0.43%	-0.62%	1.18%	-0.18%	0.5%
Net Income	335.69M	324.6M	320.37M	268.63M	42.21M	-9.58M	108.01M	62.57M	-60.41M	-99.07M
Depreciation & Amortization	64.23M	89.26M	102.88M	111.28M	25.93M	28.44M	32.15M	35.64M	36.17M	33.18M
Stock-Based Compensation	32.13M	34M	29.57M	38.7M	33.41M	39.04M	18.97M	16.13M	12.32M	11.87M
Deferred Taxes	14.49M	18.15M	-60.07M	-24.15M	-55.72M	36.29M	-31.24M	-22.77M	3.24M	-2.13M
Other Non-Cash Items	-2.49M	3.99M	981K	-7.42M	295.85M	57.7M	-27.8M	43.55M	157.63M	174.49M
Working Capital Changes	-75.35M	-26.22M	117.65M	-97.11M	16.03M	52.73M	-23.36M	31.83M	-11.63M	88.24M
Change in Receivables	-55.39M	-34M	7.8M	-36.6M	-17.61M	31.01M	-72.73M	-5.54M	26.28M	10.29M
Change in Inventory	-7.37M	-3.02M	70.26M	-66.73M	0	0	0	0	0	0
Change in Payables	-7.87M	11.62M	24.55M	15.39M	46.2M	47.91M	21.33M	420K	0	51.14M
Cash from Investing+	-848M	-821.22M	-576.61M	-142.77M	102.45M	815.51M	-53.07M	-56.95M	-48.18M	-35.41M
Capital Expenditures	-27.07M	-39.26M	-49.31M	-48.87M	-19.27M	-28.79M	-32.25M	-29.71M	-33.33M	-22.02M
CapEx % of Revenue	0.01%	0.01%	0.01%	0.01%	0.01%	0.02%	0.02%	0.02%	0.02%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-2.02M	-19.65M	6.71M	-18.39M	152.69M	874.94M	2.93M	1.38M	807K	6.83M
Cash from Financing+	482.94M	381.56M	89.74M	-170.61M	-393.07M	-4.16M	-760.12M	-487.55M	-25.71M	-14.48M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-15.46M	-6.5M	14.59M	2.55M	-19.55M	-1.51M	407K	732K	-10.59M	-1.03M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	341.63M	404.51M	462.07M	241.06M	338.44M	175.83M	44.49M	137.23M	104M	184.55M
FCF Margin %	0.12%	0.13%	0.13%	0.07%	0.19%	0.1%	0.02%	0.07%	0.05%	0.09%
FCF Growth %	-0.16%	0.18%	0.14%	-0.48%	0.4%	-0.48%	-0.75%	2.08%	-0.24%	0.77%
FCF per Share	3.64	4.32	4.93	2.63	4.02	2.05	0.51	1.63	1.27	2.21
FCF Conversion (FCF/Net Income)	1.10x	1.37x	1.60x	1.08x	-0.24x	-0.26x	0.59x	2.52x	-2.27x	-2.09x
Interest Paid	20.37M	60.45M	73.84M	82.54M	95.44M	110.49M	86.54M	116.23M	42.28M	40M
Taxes Paid	181M	175.96M	75.43M	185.42M	86.27M	0	54.73M	26.91M	30.84M	4.67M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	14.3%	12.5%	11%	8.73%	-65.3%	-70.9%	15.93%	7.42%	-6.94%	-12.28%
Return on Invested Capital (ROIC)	12.98%	10.62%	7.77%	6.77%	3.14%	3.19%	10.13%	8.16%	0.36%	-3.85%
Gross Margin	33.38%	32.47%	28.92%	27.13%	28.27%	25.91%	26.85%	23.68%	21.13%	22.57%
Net Margin	12.1%	10.21%	9.26%	7.37%	-84.15%	-45.93%	6.85%	3.36%	-3.03%	-4.92%
Debt / Equity	0.52x	0.62x	0.60x	0.64x	1.20x	2.41x	1.19x	0.80x	0.83x	0.87x
Interest Coverage	24.14x	9.06x	6.44x	4.80x	1.44x	0.89x	2.95x	4.35x	0.17x	-1.69x
FCF Conversion	1.10x	1.37x	1.60x	1.08x	-0.24x	-0.26x	0.59x	2.52x	-2.27x	-2.09x
Revenue Growth	13.98%	14.5%	8.64%	5.46%	-51.2%	-2.57%	10.22%	3.18%	1.15%	0.92%

Revenue by Segment

	2018	2019	2020	2021	2022	2023	2024
Health Care, Patient Service	3.07B	3.09B	1.48B	1.64B	1.69B	1.72B	1.72B
Health Care, Patient Service Growth	-	0.79%	-52.09%	10.80%	2.89%	1.63%	0.42%
Hospitals Contracts	363.37M	396.81M	218.5M	240.02M	262.93M	275.68M	286.68M
Hospitals Contracts Growth	-	9.20%	-44.94%	9.85%	9.54%	4.85%	3.99%
Product and Service, Other	-	24.74M	34.13M	29.85M	20.27M	2.6M	2.63M
Product and Service, Other Growth	-	-	37.93%	-12.54%	-32.08%	-87.20%	1.39%
Management Service	215.97M	-	-	-	-	-	-
Management Service Growth	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Pediatrix Medical Group, Inc. (MD) reported $1.92B in revenue for fiscal year 2024. This represents a 21% increase from $1.59B in 2011.

Pediatrix Medical Group, Inc. (MD) grew revenue by 0.9% over the past year. Growth has been modest.

Yes, Pediatrix Medical Group, Inc. (MD) is profitable, generating $162.2M in net income for fiscal year 2024 (-4.9% net margin).

Dividend & Returns

Pediatrix Medical Group, Inc. (MD) has a return on equity (ROE) of -12.3%. Negative ROE indicates the company is unprofitable.

Pediatrix Medical Group, Inc. (MD) generated $273.4M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Pediatrix Medical Group, Inc. (MD) 10-Year Financial Performance & Capital Metrics

MD • • Industrial / General

HealthcareHealthcare FacilitiesSpecialized Medical ServicesPediatric & Maternal Specialists

Revenue $2.01B +0.9%
EBITDA -$36M -183.9%
Net Income -$99M -64.0%
EPS (Diluted) -1.19 -63.0%
Gross Margin 22.57% +6.8%
EBITDA Margin -1.81% -183.1%
Operating Margin -3.41% -1030.1%
Net Margin -4.92% -62.5%
ROE -12.28% -76.9%
ROIC -3.85% -1179.4%
Debt/Equity 0.87 +4.8%
Interest Coverage -1.69 -1069.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 81 (top 19%)

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-1.9%

5Y2.49%

3Y1.74%

TTM-4.21%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM163.89%

EPS CAGR

10Y-

5Y-

3Y-

TTM161.44%

ROCE

10Y Avg6.45%

5Y Avg3.11%

3Y Avg1.57%

Latest-3.87%

Peer Comparison

Pediatric & Maternal Specialists

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
MDPediatrix Medical Group, Inc.	1.95B	22.67	-19.05	0.92%	8.44%	18.21%	9.48%	0.87

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.78B	3.18B	3.46B	3.65B	1.78B	1.73B	1.91B	1.97B	1.99B	2.01B
Revenue Growth %	0.14%	0.15%	0.09%	0.05%	-0.51%	-0.03%	0.1%	0.03%	0.01%	0.01%
Cost of Goods Sold+	1.85B	2.15B	2.46B	2.66B	1.28B	1.28B	1.4B	1.5B	1.57B	1.56B
COGS % of Revenue	0.67%	0.68%	0.71%	0.73%	0.72%	0.74%	0.73%	0.76%	0.79%	0.77%
Gross Profit+	928.01M	1.03B	1B	989.51M	503.09M	449.32M	513.24M	467.03M	421.56M	454.34M
Gross Margin %	0.33%	0.32%	0.29%	0.27%	0.28%	0.26%	0.27%	0.24%	0.21%	0.23%
Gross Profit Growth %	0.15%	0.11%	-0.03%	-0.01%	-0.49%	-0.11%	0.14%	-0.09%	-0.1%	0.08%
Operating Expenses+	370.14M	461.84M	519.98M	543.66M	331.33M	351.19M	310.32M	294.35M	414.24M	523.06M
OpEx % of Revenue	0.13%	0.15%	0.15%	0.15%	0.19%	0.2%	0.16%	0.15%	0.21%	0.26%
Selling, General & Admin	305.92M	372.57M	417.11M	432.38M	244.51M	248.95M	263.36M	231.4M	227.54M	238.44M
SG&A % of Revenue	0.11%	0.12%	0.12%	0.12%	0.14%	0.14%	0.14%	0.12%	0.11%	0.12%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	64.23M	89.26M	102.88M	111.28M	86.82M	102.24M	46.97M	62.95M	186.7M	284.62M
Operating Income+	557.87M	571.69M	480.08M	445.85M	171.76M	98.13M	202.92M	172.69M	7.32M	-68.71M
Operating Margin %	0.2%	0.18%	0.14%	0.12%	0.1%	0.06%	0.11%	0.09%	0%	-0.03%
Operating Income Growth %	0.09%	0.02%	-0.16%	-0.07%	-0.61%	-0.43%	1.07%	-0.15%	-0.96%	-10.39%
EBITDA+	622.1M	660.95M	582.96M	529.68M	197.69M	126.57M	235.06M	208.32M	43.49M	-36.49M
EBITDA Margin %	0.22%	0.21%	0.17%	0.15%	0.11%	0.07%	0.12%	0.11%	0.02%	-0.02%
EBITDA Growth %	0.11%	0.06%	-0.12%	-0.09%	-0.63%	-0.36%	0.86%	-0.11%	-0.79%	-1.84%
D&A (Non-Cash Add-back)	64.23M	89.26M	102.88M	83.83M	25.93M	28.44M	32.15M	35.64M	36.17M	32.23M
EBIT	557.87M	571.69M	460.23M	443.85M	177.71M	117.63M	203.95M	121.06M	-6.28M	-60.6M
Net Interest Income+	-23.11M	-63.09M	-74.56M	-92.94M	-118.93M	-110.48M	-68.72M	-39.7M	-42.08M	-40.74M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	23.11M	63.09M	74.56M	92.94M	118.93M	110.48M	68.72M	39.7M	42.08M	40.74M
Other Income/Expense	-18.14M	-57.89M	-69.65M	120.45M	-112.97M	-90.98M	-67.69M	-91.32M	-55.68M	-32.63M
Pretax Income+	539.73M	513.8M	410.42M	368.84M	58.78M	7.15M	135.23M	81.37M	-48.36M	-101.34M
Pretax Margin %	0.19%	0.16%	0.12%	0.1%	0.03%	0%	0.07%	0.04%	-0.02%	-0.05%
Income Tax+	204.04M	189.2M	90.05M	100.21M	16.58M	16.73M	27.24M	18.81M	12.05M	-2.27M
Effective Tax Rate %	0.62%	0.63%	0.78%	0.73%	-25.48%	-111.43%	0.97%	0.82%	1.25%	0.98%
Net Income+	336.32M	324.91M	320.37M	268.63M	-1.5B	-796.49M	130.96M	66.33M	-60.41M	-99.07M
Net Margin %	0.12%	0.1%	0.09%	0.07%	-0.84%	-0.46%	0.07%	0.03%	-0.03%	-0.05%
Net Income Growth %	0.06%	-0.03%	-0.01%	-0.16%	-6.58%	0.47%	1.16%	-0.49%	-1.91%	-0.64%
Net Income (Continuing)	335.69M	324.6M	305.44M	258.61M	42.21M	-9.58M	107.99M	62.56M	-60.41M	-99.07M
Discontinued Operations	0	0	14.93M	147.12M	-1.54B	-786.91M	22.95M	3.77M	0	0
Minority Interest	318K	0	0	0	0	232K	205K	0	0	0
EPS (Diluted)+	3.58	3.47	3.42	2.93	-17.94	-9.55	1.52	0.79	-0.73	-1.19
EPS Growth %	0.13%	-0.03%	-0.01%	-0.14%	-7.12%	0.47%	1.16%	-0.48%	-1.92%	-0.63%
EPS (Basic)	3.59	3.47	3.42	2.95	-17.78	-9.31	1.52	0.80	-0.72	-1.19
Diluted Shares Outstanding	93.96M	93.72M	93.72M	91.61M	84.25M	85.59M	86.42M	84.12M	82.2M	83.33M
Basic Shares Outstanding	93.74M	92.42M	92.43M	91.1M	84.25M	85.59M	86.42M	82.95M	84.02M	83.33M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	527.77M	587.13M	627.24M	657.41M	731.51M	1.55B	840.56M	427.99M	483.45M	639.61M
Cash & Short-Term Investments	60.42M	66.98M	70.49M	58.67M	182.38M	1.23B	487.11M	103.06M	177.74M	348.51M
Cash Only	51.57M	55.7M	60.2M	36.74M	107.87M	1.12B	387.39M	9.82M	73.26M	229.94M
Short-Term Investments	8.85M	11.29M	10.29M	21.92M	74.51M	104.87M	99.72M	93.24M	104.48M	118.57M
Accounts Receivable	444.74M	495.28M	504M	506.72M	434.27M	241.93M	316.02M	296.79M	279.88M	272.6M
Days Sales Outstanding	58.39	56.79	53.19	50.71	89.06	50.93	60.35	54.93	51.22	49.43
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	12.97M	13.82M	37.16M	88.72M	97.75M	61.81M	18.9M	13.26M	12.31M	5.09M
Total Non-Current Assets+	4.02B	4.75B	5.24B	5.28B	3.41B	1.8B	1.88B	1.92B	1.74B	1.51B
Property, Plant & Equipment	83.63M	103.07M	123.54M	133.04M	129.09M	132.16M	135.62M	140.21M	145.93M	78.44M
Fixed Asset Turnover	33.24x	30.88x	27.99x	27.41x	13.79x	13.12x	14.09x	14.06x	13.67x	25.66x
Goodwill	3.37B	4.08B	4.6B	4.69B	1.48B	1.48B	1.51B	1.53B	1.38B	1.24B
Intangible Assets	424.22M	668.53M	639.93M	588.31M	28.59M	26.64M	21.57M	18.49M	21.24M	11.6M
Long-Term Investments	63.29M	78.97M	80.68M	69.7M	0	0	0	0	0	0
Other Non-Current Assets	-335.88M	-409.85M	-352.01M	-333.98M	1.69B	107.36M	131.03M	123.18M	82.17M	76.6M
Total Assets+	4.55B	5.34B	5.87B	5.93B	4.15B	3.35B	2.72B	2.35B	2.22B	2.15B
Asset Turnover	0.61x	0.60x	0.59x	0.61x	0.43x	0.52x	0.70x	0.84x	0.90x	0.94x
Asset Growth %	0.26%	0.17%	0.1%	0.01%	-0.3%	-0.19%	-0.19%	-0.14%	-0.05%	-0.03%
Total Current Liabilities+	395.81M	407.94M	438.02M	469.34M	541.82M	444.33M	427.37M	426.98M	388.95M	434.11M
Accounts Payable	21.97M	28.47M	34.63M	31.06M	35.41M	59.77M	36.65M	31.86M	34.59M	46.43M
Days Payables Outstanding	4.33	4.83	5.14	4.27	10.12	16.98	9.57	7.73	8.03	10.87
Short-Term Debt	11.88M	22.05M	1.4M	253K	0	0	0	12.5M	12.5M	18.75M
Deferred Revenue (Current)	-1000K	-1000K	-1000K	-1000K	0	0	0	0	0	0
Other Current Liabilities	100.56M	107.9M	192.89M	149.89M	106.89M	0	0	0	0	0
Current Ratio	1.33x	1.44x	1.43x	1.40x	1.35x	3.49x	1.97x	1.00x	1.24x	1.47x
Quick Ratio	1.33x	1.44x	1.43x	1.40x	1.35x	3.49x	1.97x	1.00x	1.24x	1.47x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	1.71B	2.17B	2.36B	2.38B	2.11B	2.16B	1.4B	1.03B	981.8M	953.65M
Long-Term Debt	1.26B	1.68B	1.85B	1.97B	1.73B	1.73B	1B	627.65M	611.59M	593.57M
Capital Lease Obligations	2.42M	1.5M	0	188K	44.64M	49.87M	41.4M	52.94M	54.07M	35.49M
Deferred Tax Liabilities	188.96M	227.8M	147.8M	131.24M	56.47M	61.75M	41.41M	33.64M	34.31M	34.25M
Other Non-Current Liabilities	228.82M	218.25M	418.4M	372.55M	273.74M	310.62M	313.43M	315.04M	281.84M	290.34M
Total Liabilities	2.11B	2.58B	2.8B	2.85B	2.65B	2.6B	1.83B	1.46B	1.37B	1.39B
Total Debt+	1.27B	1.71B	1.85B	1.97B	1.79B	1.8B	1.07B	717.08M	701.65M	662.31M
Net Debt	1.22B	1.65B	1.79B	1.94B	1.69B	680.84M	678.44M	707.26M	628.39M	432.37M
Debt / Equity	0.52x	0.62x	0.60x	0.64x	1.20x	2.41x	1.19x	0.80x	0.83x	0.87x
Debt / EBITDA	2.05x	2.58x	3.18x	3.73x	9.07x	14.26x	4.53x	3.44x	16.13x	-
Net Debt / EBITDA	1.97x	2.50x	3.08x	3.66x	8.52x	5.38x	2.89x	3.39x	14.45x	-
Interest Coverage	24.14x	9.06x	6.44x	4.80x	1.44x	0.89x	2.95x	4.35x	0.17x	-1.69x
Total Equity+	2.44B	2.76B	3.07B	3.09B	1.5B	747.72M	896.69M	891.63M	849.06M	764.94M
Equity Growth %	0.08%	0.13%	0.11%	0.01%	-0.51%	-0.5%	0.2%	-0.01%	-0.05%	-0.1%
Book Value per Share	25.95	29.46	32.72	33.71	17.79	8.74	10.38	10.60	10.33	9.18
Total Shareholders' Equity	2.44B	2.76B	3.07B	3.09B	1.5B	747.49M	896.49M	891.63M	849.06M	764.94M
Common Stock	937K	937K	937K	878K	842K	856K	864K	829K	840K	859K
Retained Earnings	1.51B	1.79B	2.05B	2.09B	510.13M	-286.35M	-155.39M	-89.06M	-149.47M	-248.54M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-119.33M	-143.71M	-169.62M	-207.82M	78K	3.53M	1.32M	-3.73M	-2.21M	-1.07M
Minority Interest	318K	0	0	0	0	232K	205K	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	368.7M	443.78M	511.38M	289.93M	357.71M	204.62M	76.74M	166.94M	137.32M	206.57M
Operating CF Margin %	0.13%	0.14%	0.15%	0.08%	0.2%	0.12%	0.04%	0.08%	0.07%	0.1%
Operating CF Growth %	-0.13%	0.2%	0.15%	-0.43%	0.23%	-0.43%	-0.62%	1.18%	-0.18%	0.5%
Net Income	335.69M	324.6M	320.37M	268.63M	42.21M	-9.58M	108.01M	62.57M	-60.41M	-99.07M
Depreciation & Amortization	64.23M	89.26M	102.88M	111.28M	25.93M	28.44M	32.15M	35.64M	36.17M	33.18M
Stock-Based Compensation	32.13M	34M	29.57M	38.7M	33.41M	39.04M	18.97M	16.13M	12.32M	11.87M
Deferred Taxes	14.49M	18.15M	-60.07M	-24.15M	-55.72M	36.29M	-31.24M	-22.77M	3.24M	-2.13M
Other Non-Cash Items	-2.49M	3.99M	981K	-7.42M	295.85M	57.7M	-27.8M	43.55M	157.63M	174.49M
Working Capital Changes	-75.35M	-26.22M	117.65M	-97.11M	16.03M	52.73M	-23.36M	31.83M	-11.63M	88.24M
Change in Receivables	-55.39M	-34M	7.8M	-36.6M	-17.61M	31.01M	-72.73M	-5.54M	26.28M	10.29M
Change in Inventory	-7.37M	-3.02M	70.26M	-66.73M	0	0	0	0	0	0
Change in Payables	-7.87M	11.62M	24.55M	15.39M	46.2M	47.91M	21.33M	420K	0	51.14M
Cash from Investing+	-848M	-821.22M	-576.61M	-142.77M	102.45M	815.51M	-53.07M	-56.95M	-48.18M	-35.41M
Capital Expenditures	-27.07M	-39.26M	-49.31M	-48.87M	-19.27M	-28.79M	-32.25M	-29.71M	-33.33M	-22.02M
CapEx % of Revenue	0.01%	0.01%	0.01%	0.01%	0.01%	0.02%	0.02%	0.02%	0.02%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-2.02M	-19.65M	6.71M	-18.39M	152.69M	874.94M	2.93M	1.38M	807K	6.83M
Cash from Financing+	482.94M	381.56M	89.74M	-170.61M	-393.07M	-4.16M	-760.12M	-487.55M	-25.71M	-14.48M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-15.46M	-6.5M	14.59M	2.55M	-19.55M	-1.51M	407K	732K	-10.59M	-1.03M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	341.63M	404.51M	462.07M	241.06M	338.44M	175.83M	44.49M	137.23M	104M	184.55M
FCF Margin %	0.12%	0.13%	0.13%	0.07%	0.19%	0.1%	0.02%	0.07%	0.05%	0.09%
FCF Growth %	-0.16%	0.18%	0.14%	-0.48%	0.4%	-0.48%	-0.75%	2.08%	-0.24%	0.77%
FCF per Share	3.64	4.32	4.93	2.63	4.02	2.05	0.51	1.63	1.27	2.21
FCF Conversion (FCF/Net Income)	1.10x	1.37x	1.60x	1.08x	-0.24x	-0.26x	0.59x	2.52x	-2.27x	-2.09x
Interest Paid	20.37M	60.45M	73.84M	82.54M	95.44M	110.49M	86.54M	116.23M	42.28M	40M
Taxes Paid	181M	175.96M	75.43M	185.42M	86.27M	0	54.73M	26.91M	30.84M	4.67M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	14.3%	12.5%	11%	8.73%	-65.3%	-70.9%	15.93%	7.42%	-6.94%	-12.28%
Return on Invested Capital (ROIC)	12.98%	10.62%	7.77%	6.77%	3.14%	3.19%	10.13%	8.16%	0.36%	-3.85%
Gross Margin	33.38%	32.47%	28.92%	27.13%	28.27%	25.91%	26.85%	23.68%	21.13%	22.57%
Net Margin	12.1%	10.21%	9.26%	7.37%	-84.15%	-45.93%	6.85%	3.36%	-3.03%	-4.92%
Debt / Equity	0.52x	0.62x	0.60x	0.64x	1.20x	2.41x	1.19x	0.80x	0.83x	0.87x
Interest Coverage	24.14x	9.06x	6.44x	4.80x	1.44x	0.89x	2.95x	4.35x	0.17x	-1.69x
FCF Conversion	1.10x	1.37x	1.60x	1.08x	-0.24x	-0.26x	0.59x	2.52x	-2.27x	-2.09x
Revenue Growth	13.98%	14.5%	8.64%	5.46%	-51.2%	-2.57%	10.22%	3.18%	1.15%	0.92%

Revenue by Segment

	2018	2019	2020	2021	2022	2023	2024
Health Care, Patient Service	3.07B	3.09B	1.48B	1.64B	1.69B	1.72B	1.72B
Health Care, Patient Service Growth	-	0.79%	-52.09%	10.80%	2.89%	1.63%	0.42%
Hospitals Contracts	363.37M	396.81M	218.5M	240.02M	262.93M	275.68M	286.68M
Hospitals Contracts Growth	-	9.20%	-44.94%	9.85%	9.54%	4.85%	3.99%
Product and Service, Other	-	24.74M	34.13M	29.85M	20.27M	2.6M	2.63M
Product and Service, Other Growth	-	-	37.93%	-12.54%	-32.08%	-87.20%	1.39%
Management Service	215.97M	-	-	-	-	-	-
Management Service Growth	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Pediatrix Medical Group, Inc. (MD) reported $1.92B in revenue for fiscal year 2024. This represents a 21% increase from $1.59B in 2011.

Pediatrix Medical Group, Inc. (MD) grew revenue by 0.9% over the past year. Growth has been modest.

Yes, Pediatrix Medical Group, Inc. (MD) is profitable, generating $162.2M in net income for fiscal year 2024 (-4.9% net margin).

Dividend & Returns

Pediatrix Medical Group, Inc. (MD) has a return on equity (ROE) of -12.3%. Negative ROE indicates the company is unprofitable.

Pediatrix Medical Group, Inc. (MD) generated $273.4M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.